Navigation Links
Endexx identifies core platform for Medical Marijuana Industry
Date:2/19/2013

PHOENIX, Feb. 19, 2013 /PRNewswire/ -- Endexx Corporation (OTC Markets: EDXC) announces that it has entered into a Letter of Agreement and Memorandum of Understanding to purchase and acquire from Hayes Pharmacy Inc. (a Texas Corporation), the exclusive operating technology, intellectual property, marketing and ownership rights to a proprietary pharmaceutical/pharmacy compliance, controls, privacy, verification and operations platform. The platform is specifically designed to service the medical marijuana industry and long term chronic pharmaceutical patient care arena. Upon completion of due diligence and closing of the transaction, Endexx will report details of the business going forward.

Contact: Todd Davis CEO

EndexxCorporation@yahoo.com

http://www.otcmarkets.com/stock/EDXC/quote

www.endexx.com 

Safe Harbor Statement

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.

 

 


'/>"/>
SOURCE Endexx Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Research Group Identifies the Top Ten Trends in Medical Device Markets for 2013
2. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
3. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
4. Pearl Therapeutics Completes Phase 2b Study of Glycopyrrolate, Defines Dose-Response Curve and Identifies Optimal Dose of PT001
5. Verizon Identifies 10 Most Promising Ways to Use Health IT to Enhance Patient Care, Reduce Costs
6. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
7. Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
8. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
9. Phreesia identifies over 26% of patients who require additional autism evaluation
10. San Diego-Based Wellaho Receives FDA Approval For its Mobile and Web Platform for Patients with Chronic Conditions
11. ProGaming Platforms Corp. Executes Share Swap Agreement With BioMedix Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):